288 related articles for article (PubMed ID: 23062988)
1. Implications of treatment that target protective mechanisms against diabetic nephropathy.
Mima A; Qi W; King GL
Semin Nephrol; 2012 Sep; 32(5):471-8. PubMed ID: 23062988
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycemia to nephropathy via transforming growth factor beta.
Garud MS; Kulkarni YA
Curr Diabetes Rev; 2014 May; 10(3):182-9. PubMed ID: 24919657
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy.
Yang J; Liu Z
Front Endocrinol (Lausanne); 2022; 13():816400. PubMed ID: 35692405
[TBL] [Abstract][Full Text] [Related]
4. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.
Sanajou D; Ghorbani Haghjo A; Argani H; Aslani S
Eur J Pharmacol; 2018 Aug; 833():158-164. PubMed ID: 29883668
[TBL] [Abstract][Full Text] [Related]
5. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
6. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms.
Tonna S; El-Osta A; Cooper ME; Tikellis C
Nat Rev Nephrol; 2010 Jun; 6(6):332-41. PubMed ID: 20421885
[TBL] [Abstract][Full Text] [Related]
7. VEGF and podocytes in diabetic nephropathy.
Tufro A; Veron D
Semin Nephrol; 2012 Jul; 32(4):385-93. PubMed ID: 22958493
[TBL] [Abstract][Full Text] [Related]
8. Future of interventions in diabetic nephropathy: antioxidants.
Ha H; Kim KH
Perit Dial Int; 1999; 19 Suppl 2():S228-33. PubMed ID: 10406524
[No Abstract] [Full Text] [Related]
9. The Role of Dietary Antioxidants on Oxidative Stress in Diabetic Nephropathy.
Gerardo Yanowsky-Escatell F; Andrade-Sierra J; Pazarín-Villaseñor L; Santana-Arciniega C; De Jesús Torres-Vázquez E; Samuel Chávez-Iñiguez J; Ángel Zambrano-Velarde M; Martín Preciado-Figueroa F
Iran J Kidney Dis; 2020 Mar; 14(2):81-94. PubMed ID: 32165592
[TBL] [Abstract][Full Text] [Related]
10. Novel inhibitors of glycation and AGE formation.
Rahbar S
Cell Biochem Biophys; 2007; 48(2-3):147-57. PubMed ID: 17709884
[TBL] [Abstract][Full Text] [Related]
11. A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction.
Yu Y; Lyons TJ
Am J Med Sci; 2005 Nov; 330(5):227-32. PubMed ID: 16284482
[TBL] [Abstract][Full Text] [Related]
12. Molecular understanding of hyperglycemia's adverse effects for diabetic complications.
Sheetz MJ; King GL
JAMA; 2002 Nov; 288(20):2579-88. PubMed ID: 12444865
[TBL] [Abstract][Full Text] [Related]
13. Microvascular complications of diabetes mellitus: renal protection accompanies cardiovascular protection.
Brown WV
Am J Cardiol; 2008 Dec; 102(12A):10L-13L. PubMed ID: 19084084
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products and diabetic complications.
Stitt AW; Jenkins AJ; Cooper ME
Expert Opin Investig Drugs; 2002 Sep; 11(9):1205-23. PubMed ID: 12225243
[TBL] [Abstract][Full Text] [Related]
15. [Molecular bases of diabetic nephropathy].
Lagranha CJ; Fiorino P; Casarini DE; Schaan BD; Irigoyen MC
Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):901-12. PubMed ID: 17934656
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products, oxidative stress and diabetic nephropathy.
Yamagishi S; Matsui T
Oxid Med Cell Longev; 2010; 3(2):101-8. PubMed ID: 20716934
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products and the pathogenesis of diabetic nephropathy.
Yamagishi S; Takeuchi M; Makita Z
Contrib Nephrol; 2001; (134):30-5. PubMed ID: 11665285
[No Abstract] [Full Text] [Related]
18. Oxidative stress in early diabetic nephropathy: fueling the fire.
Singh DK; Winocour P; Farrington K
Nat Rev Endocrinol; 2011 Mar; 7(3):176-84. PubMed ID: 21151200
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products and diabetic nephropathy.
Thomas MC; Forbes JM; Cooper ME
Am J Ther; 2005; 12(6):562-72. PubMed ID: 16280650
[TBL] [Abstract][Full Text] [Related]
20. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
Elmarakby AA; Sullivan JC
Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
